Niklas Gebauer

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Nora Liebers, Johannes Duell, Donnacha Fitzgerald et al. · Blood Advances · 2021 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Global microRNA profiling of pancreatic neuroendocrine neoplasias.

C. Thorns, Claudia Schurmann, Niklas Gebauer et al. · PubMed · 2014 · 89 citations

Medicine, Oncology, Pathology +17

Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)

D Gagiannis, Julie Steinestel, Carsten Hackenbroch et al. · Frontiers in Immunology · 2020 · 75 citations · Full text

Medicine, Infectious Diseases, Pathology +17

<i>TP53</i>mutations are frequent events in double-hit B-cell lymphomas with<i>MYC</i>and<i>BCL2</i>but not<i>MYC</i>and<i>BCL6</i>translocations

Niklas Gebauer, Veronica Bernard, Wolfgang Gebauer et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 68 citations

Medicine, Molecular Biology, Oncology +17

Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing

Niklas Gebauer, Axel Künstner, Julius Ketzer et al. · Blood Cancer Journal · 2021 · 56 citations · Full text

Medicine, Oncology, Pathology +17